Philadelphia Jury Awards Three Women $72M Over Prempro Therapy Drug
A Philadelphia jury has awarded three women $72.6 million in compensatory damages over their use of the hormone therapy drug Prempro and more could be coming when punitive damages are determined.
The Philadelphia Inquirer reports the Common Pleas Court jury on Tuesday ordered pharmaceutical giant Pfizer Inc. to pay out the damages over the plaintiffs’ claims the menopause drug gave them breast cancer. The jury could take two weeks to determine punitive damages.
The three women who sued over the drug live or lived in Pennsylvania. Wyeth Pharmaceuticals was hit with dozens of lawsuits after a study found Prempro users had a much higher incidence of breast cancer.
Pfizer bought Wyeth in 2009. A spokesman tells The Inquirer the company will examine its options after the verdict is final.
- Insurance Executive Killed His Wife, Daughter, Then Himself, NJ Township Police Say
- ‘Unusual’ Isaias Brings Winds, Downed Trees But Fewer Claims Than Expected
- Harbor Emerges From Stealth with $10M Funding to Handle AI-Agent Risk
- AI Models May Soon Self-Replicate Across Smart-Home Devices, Anthropic Warns